Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Cannabis topic
No spam. Unsubscribe anytime.
Senate committee amends HB302 to ease dispensary transfers and clarify medical cannabis retailing
Summary
The Senate Committee on Health and Human Services voted March 19 to pass HB302 with amendments that redefine qualifying-condition language, establish a waiting‑room category for nonmedical retail items, and permit limited inter‑dispensary purchases and transfers under Department of Health rules.
The Senate Committee on Health and Human Services voted March 19 to pass House Bill 302 with a package of amendments aimed at clarifying patient access and the retail operations of licensed medical dispensaries.
Why it matters: Testimony during the hearing emphasized access for patients in outlying islands and the need to modernize regulatory language to reflect current dispensing and supply practices. Advocates urged removing in‑person provider requirements and streamlining registration to improve access for patients who cannot easily reach certifying providers.
The committee accepted an amendment from Akamai Cannabis Consulting to redefine “debilitating medical condition” to provide clearer statutory language. The committee also adopted a waiting‑room definition that designates a retail area where nonmedical cannabis items (end products and accessories) may be sold, and it added statutory language authorizing dispensing licensees to purchase cannabis and manufactured cannabis products from other licensed dispensaries under rules promulgated by the Department of Health (HRS chapter 329D rulemaking). That amendment includes a transport limit (the selling dispensary may transport not more than 800 ounces to a purchasing dispensary within a 30‑day period, subject to Department rules) and requires a transport manifest be submitted to the department before transfers occur.
Other changes inserted technical language from related measures (including language previously approved by the committee in senate bill 1064 SD2) and set a defective effective date of Dec. 31, 2050 for the substituted language. Supporters at the hearing included Andrew Goff of the Department of Health’s Office of Medical Cannabis (testifying in support), representatives of industry groups and civil‑liberties organizations such as the ACLU, and patient advocates who said the bill would improve access for remote patients.
Committee members had no further questions after the amendment recitation, and the committee recommended passage with amendments. The committee record shows multiple members voting to pass the bill with amendments; the chair announced the recommendation to pass with amendments and recorded the chair and vice‑chair voting aye, followed by additional aye votes from committee senators.
What’s next: HB302 as amended moves forward in the legislative process with instructions in the committee report to include the adopted technical and policy language. The Department of Health will implement transfer rules and the transport manifest process through its rulemaking authority under HRS chapter 329D.
